Back to today’s briefing

Story perspectives

Revolutionary Cancer Therapies: UChicago's Quest for Better Outcomes

8/5/2025

50 10

Summary

Story summary

Immunotherapy has transformed cancer care since the FDA's 2011 approval of the first checkpoint inhibitor, sparking remarkable patient remissions. At UChicago, researchers are delving into innovative therapies like CAR T-cell and tumor-infiltrating lymphocyte treatments, seeking powerful combinations with radiation to boost effectiveness. A deeper understanding of tumor microenvironments is key to elevating patient outcomes.

1 of 1

Story summary

Immunotherapy has transformed cancer care since the FDA's 2011 approval of the first checkpoint inhibitor, sparking remarkable patient remissions. At UChicago, researchers are delving into innovative therapies like CAR T-cell and tumor-infiltrating lymphocyte treatments, seeking powerful combinations with radiation to boost effectiveness. A deeper understanding of tumor microenvironments is key to elevating patient outcomes.